Abstract
Hormone replacement therapy (HRT) is increasingly prescribed for menopausal symptoms and its many other benefits include lessening the risks of osteoporosis and ischemic heart disease. Breast cancer survivors are often refused HRT because of a rheotorical risk of recurrence.